# Cue Biopharma, Inc.: Form 8-K, filed Aug 16, 2024

- Company: [Cue Biopharma, Inc.](/companies/cue.md) (CIK 1645460)
- Form: 8-K
- Filed: 2024-08-16
- Accepted by EDGAR: Aug 16, 2024, 20:00 ET
- Period: 2024-08-15
- Accession: 0000950170-24-098032
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1645460/000095017024098032/cue-20240815.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1645460/000095017024098032/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1645460/000095017024098032/cue-20240815.htm

Filed Aug 16, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-098032. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.